Kent Savage is the founder of PhotoPharmics. PhotoPharmics has raised $22M in total funding. Latest round: Series B. Backed by Kickstart Fund.
Kent Savage is the Co-founder and CEO of PhotoPharmics, a clinical-stage neurotechnology company. The company develops light-based therapies for neurodegenerative diseases like Parkinson's disease. He leads the company's mission to revolutionize Parkinson's treatment through its FDA breakthrough therapeutic device, Celeste.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide